Work

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes

Year: 2018

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2018.12.005

Authors: Rami S. Komrokji, Sheng Wei, Adam W. Mailloux, Ling Zhang, Eric Padron, David Sallman, Jeffrey E. Lancet, Sara Tinsley, Lisa A. Nardelli, Javier Pinilla-Ibarz, Pearlie K. Epling-Burnette, Alan F. List

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Incyte

OpenAlex ID: W2904882306

FWCI: 4.123

Cites: 13

Cited by: 40

Related to: 10